BRACHYTHERAPY;
CANCER CENTER;
CANCER RADIOTHERAPY;
HEALTH CARE POLICY;
HUMAN;
INTENSITY MODULATED RADIATION THERAPY;
ONCOLOGY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROSTATE CANCER;
RADIATION BEAM;
REIMBURSEMENT;
REVIEW;
TECHNOLOGY;
UNITED STATES;
COSTS AND COST ANALYSIS;
CRITICAL PATHWAYS;
GUIDELINE ADHERENCE;
HUMANS;
MEDICARE;
RADIATION ONCOLOGY;
RADIOTHERAPY, INTENSITY-MODULATED;
REIMBURSEMENT MECHANISMS;
UNITED STATES;
Documenting the benefits and cost savings of a large multistate cancer pathway program from a payer's perspective
E.D. Kreys, and J.M. Koeller Documenting the benefits and cost savings of a large multistate cancer pathway program from a payer's perspective J Oncol Pract 9 2013 e241 e247
Third-party validation of observed savings from an oncology pathways program
B. Feinberg, S. Milligan, and J. Cooper et al. Third-party validation of observed savings from an oncology pathways program Am J Manag Care SP 4 2013 SP127
Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small cell lung cancer in the community setting
M.A. Neubauer, J.R. Hoverman, and M. Kolodziej et al. Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small cell lung cancer in the community setting J Oncol Pract 6 2010 12 18
Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs
L.N. Newcomer Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs Health Aff (Millwood) 31 2012 780 785
